Clinical Trials · NCT02806414
Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.
- Phase
- Phase 1/Phase 2
- Recruitment status
- Completed
- Sponsor
- University of California, San Diego
- Enrollment
- 25
- Start date
- Jul 2016
- Locations
- 1 site, United States
- Primary endpoint
- Relative Trypsin-like Enzyme Activity